This observation indicates a typical mechanism of action that involves downregulating the pathogenic process by reducing NF-κB activation rather than merely controlling its expression level to alleviate the inflammatory response in the AD-like model HaCaT cells. Here, NFKB1 is linked to Alzheimer disease.